1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > World Generic Markets 02 FEBRUARY 2015

World Generic Markets 02 FEBRUARY 2015

  • February 2015
  • -
  • Espicom Business Intelligence
  • -
  • 24 pages

Industry Trend Analysis - AstraZeneca Will Look To Other Regions As US Generic Nexium Competition Commences
Industry Trend Analysis - Supreme Court Ruling Will Boost Teva's Copaxone Revenues
Industry Brief - Supernus Files Oxcarbazepine Patent Lawsuit Against TWi
Industry Brief - Impax Receives US Lamotrigine Approval
Industry Brief - Antares' Sumatriptan ANDA Receives CRL
Industry Brief - ANI Launches Etodolac In US
Industry Trend Analysis - Mylan's Acquisition Of Abbott's Non-US Generics Business On Track To Complete In Q115
Industry Brief - Ranbaxy Forfeits Esomeprazole Exclusivity
Industry Brief - EMA Accepts Samsung Bioepis' Etanercept Biosimilar For Review
Industry Trend Analysis - Generic Regulatory Pilot Programme Is On The Threshold Of A New Era
Industry Trend Analysis - Suspension Of GVK-Related Products Questions EU Oversight
Industry Trend Analysis - Actavis' First Acquisition Of 2015 Will Boost Its UK Generics Presence
Industry Brief - Beximco Commences Exports To Australia
Industry Brief - Strides Signs TAF Agreement With Gilead
Industry Trend Analysis - Several Stakeholders To Benefit From Gilead's Expanded Deals With Indian Generics Companies
Industry Trend Analysis - Regional Powerhouse Ahead As Sun/Ranbaxy Merger Approaches Conclusion
Industry Brief - Aspen Acquires Certoparin Rights From Novartis

Table Of Contents

World Generic Markets 02 FEBRUARY 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

2017 World Clinical Chemistry Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East—Over 100 Special Chemistry, Abused Drugs, Endocrine, Immunoprotein, TDM, Tumor MarkerTests--Supplier Shares, Competitive Strategies, Opportunities

  • $ 75000
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com provides a granular strategic analysis of over 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug assays performed in both ...

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Cancer Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

2017 World Tumor Marker Diagnostics Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales Forecasts and Strategies, Supplier Shares--Emerging Tumor Markers, Technologies and Opportunities

  • $ 52400
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 74-country survey from VPGMarketResearch.com is designed to assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding cancer diagnostic ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.